1
|
Wan B, Patel M, Zhou G, Olma M, Bieri M, Mueller M, Appiah-Amponsah E, Patel B, Jayapal K. Robust platform for inline Raman monitoring and control of perfusion cell culture. Biotechnol Bioeng 2024; 121:1688-1701. [PMID: 38393313 DOI: 10.1002/bit.28680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 01/23/2024] [Accepted: 02/12/2024] [Indexed: 02/25/2024]
Abstract
Perfusion cell culture has been gaining increasing popularity for biologics manufacturing due to benefits such as smaller footprint, increased productivity, consistent product quality and manufacturing flexibility, cost savings, and so forth. Process Analytics Technologies tools are highly desirable for effective monitoring and control of long-running perfusion processes. Raman has been widely investigated for monitoring and control of traditional fed batch cell culture process. However, implementation of Raman for perfusion cell culture has been very limited mainly due to challenges with high-cell density and long running times during perfusion which cause extremely high fluorescence interference to Raman spectra and consequently it is exceedingly difficult to develop robust chemometrics models. In this work, a platform based on Raman measurement of permeate has been proposed for effective analysis of perfusion process. It has been demonstrated that this platform can effectively circumvent the fluorescence interference issue while providing rich and timely information about perfusion dynamics to enable efficient process monitoring and robust bioreactor feed control. With the highly consistent spectral data from cell-free sample matrix, development of chemometrics models can be greatly facilitated. Based on this platform, Raman models have been developed for good measurement of several analytes including glucose, lactate, glutamine, glutamate, and permeate titer. Performance of Raman models developed this way has been systematically evaluated and the models have shown good robustness against changes in perfusion scale and variations in permeate flowrate; thus models developed from small lab scale can be directly transferred for implementation in much larger scale of perfusion. With demonstrated robustness, this platform provides a reliable approach for automated glucose feed control in perfusion bioreactors. Glucose model developed from small lab scale has been successfully implemented for automated continuous glucose feed control of perfusion cell culture at much larger scale.
Collapse
Affiliation(s)
- Boyong Wan
- Analytical Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - Misaal Patel
- Bioprocess Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - George Zhou
- Global Vaccine and Biologics Commercialization, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - Michael Olma
- Analytical Research & Development, Werthenstein Biopharma GmbH, MSD, Werthenstein, Switzerland
| | - Marco Bieri
- Analytical Research & Development, Werthenstein Biopharma GmbH, MSD, Werthenstein, Switzerland
| | - Marvin Mueller
- Analytical Research & Development, Werthenstein Biopharma GmbH, MSD, Werthenstein, Switzerland
| | | | - Bhumit Patel
- Analytical Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - Karthik Jayapal
- Bioprocess Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| |
Collapse
|
2
|
Liu Y, Zhou X, Wang T, Luo A, Jia Z, Pan X, Cai W, Sun M, Wang X, Wen Z, Zhou G. Genetic algorithm-based semisupervised convolutional neural network for real-time monitoring of Escherichia coli fermentation of recombinant protein production using a Raman sensor. Biotechnol Bioeng 2024; 121:1583-1595. [PMID: 38247359 DOI: 10.1002/bit.28661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Revised: 01/02/2024] [Accepted: 01/08/2024] [Indexed: 01/23/2024]
Abstract
As a non-destructive sensing technique, Raman spectroscopy is often combined with regression models for real-time detection of key components in microbial cultivation processes. However, achieving accurate model predictions often requires a large amount of offline measurement data for training, which is both time-consuming and labor-intensive. In order to overcome the limitations of traditional models that rely on large datasets and complex spectral preprocessing, in addition to the difficulty of training models with limited samples, we have explored a genetic algorithm-based semi-supervised convolutional neural network (GA-SCNN). GA-SCNN integrates unsupervised process spectral labeling, feature extraction, regression prediction, and transfer learning. Using only an extremely small number of offline samples of the target protein, this framework can accurately predict protein concentration, which represents a significant challenge for other models. The effectiveness of the framework has been validated in a system of Escherichia coli expressing recombinant ProA5M protein. By utilizing the labeling technique of this framework, the available dataset for glucose, lactate, ammonium ions, and optical density at 600 nm (OD600) has been expanded from 52 samples to 1302 samples. Furthermore, by introducing a small component of offline detection data for recombinant proteins into the OD600 model through transfer learning, a model for target protein detection has been retrained, providing a new direction for the development of associated models. Comparative analysis with traditional algorithms demonstrates that the GA-SCNN framework exhibits good adaptability when there is no complex spectral preprocessing. Cross-validation results confirm the robustness and high accuracy of the framework, with the predicted values of the model highly consistent with the offline measurement results.
Collapse
Affiliation(s)
- Yuan Liu
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
| | - Xiaotian Zhou
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
| | - Teng Wang
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Key Laboratory of Enze Biomass and Fine Chemicals, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Institute of Petrochemical Technology, College of New Materials and Chemical Engineering, Beijing, China
| | - An Luo
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Institute of Petrochemical Technology, College of New Materials and Chemical Engineering, Beijing, China
| | - Zhaojun Jia
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Institute of Petrochemical Technology, College of New Materials and Chemical Engineering, Beijing, China
| | - Xingquan Pan
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Institute of Petrochemical Technology, College of New Materials and Chemical Engineering, Beijing, China
| | - Weiqi Cai
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Institute of Petrochemical Technology, College of New Materials and Chemical Engineering, Beijing, China
| | - Mengge Sun
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Institute of Petrochemical Technology, College of New Materials and Chemical Engineering, Beijing, China
| | - Xuezhong Wang
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Key Laboratory of Enze Biomass and Fine Chemicals, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Institute of Petrochemical Technology, College of New Materials and Chemical Engineering, Beijing, China
| | - Zhenguo Wen
- Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Key Laboratory of Enze Biomass and Fine Chemicals, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Institute of Petrochemical Technology, College of New Materials and Chemical Engineering, Beijing, China
| | - Guangzheng Zhou
- Beijing Key Laboratory of Enze Biomass and Fine Chemicals, Beijing Institute of Petrochemical Technology, Beijing, China
- Beijing Institute of Petrochemical Technology, College of New Materials and Chemical Engineering, Beijing, China
| |
Collapse
|
3
|
Hevaganinge A, Weber CM, Filatova A, Musser A, Neri A, Conway J, Yuan Y, Cattaneo M, Clyne AM, Tao Y. Fast-Training Deep Learning Algorithm for Multiplex Quantification of Mammalian Bioproduction Metabolites via Contactless Short-Wave Infrared Hyperspectral Sensing. ACS OMEGA 2023; 8:14774-14783. [PMID: 37125125 PMCID: PMC10134457 DOI: 10.1021/acsomega.3c00861] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Accepted: 04/04/2023] [Indexed: 05/03/2023]
Abstract
Within the biopharmaceutical sector, there exists the need for a contactless multiplex sensor, which can accurately detect metabolite levels in real time for precise feedback control of a bioreactor environment. Reported spectral sensors in the literature only work when fully submerged in the bioreactor and are subject to probe fouling due to a cell debris buildup. The use of a short-wave infrared (SWIR) hyperspectral (HS) cam era allows for efficient, fully contactless collection of large spectral datasets for metabolite quantification. Here, we report the development of an interpretable deep learning system, a convolution metabolite regression (CMR) approach that detects glucose and lactate concentrations using label-free contactless HS images of cell-free spent media samples from Chinese hamster ovary (CHO) cell growth flasks. Using a dataset of <500 HS images, these CMR algorithms achieved a competitive test root-mean-square error (RMSE) performance of glucose quantification within 27 mg/dL and lactate quantification within 20 mg/dL. Conventional Raman spectroscopy probes report a validation performance of 26 and 18 mg/dL for glucose and lactate, respectively. The CMR system trains within 10 epochs and uses a convolution encoder with a sparse bottleneck regression layer to pick the best-performing filters learned by CMR. Each of these filters is combined with existing interpretable models to produce a metabolite sensing system that automatically removes spurious predictions. Collectively, this work will advance the safe and efficient adoption of contactless deep learning sensing systems for fine control of a variety of bioreactor environments.
Collapse
Affiliation(s)
- Anjana Hevaganinge
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
| | - Callie M. Weber
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
| | - Anna Filatova
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
| | - Amy Musser
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
| | - Anthony Neri
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
| | - Jessica Conway
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
| | - Yiding Yuan
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
| | - Maurizio Cattaneo
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
- Artemis
Biosystems, 39 Shore
Avenue Quincy, Woburn, Massachusetts 02169, United States
| | - Alisa Morss Clyne
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
| | - Yang Tao
- Fischell
Department of Bioengineering, University
of Maryland, 8278 Paint Branch Dr, College Park, Maryland 20742, United States
| |
Collapse
|
4
|
Esmonde-White K, Lewis M, Lewis IR. Direct Measurement of Chocolate Components Using Dispersive Raman Spectroscopy at 1000 nm Excitation. APPLIED SPECTROSCOPY 2023; 77:320-326. [PMID: 36547013 DOI: 10.1177/00037028221147941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
Chocolate is a popular food around the world. Making chocolate-based confectionaries involve multiple processing steps including cocoa bean fermentation, cocoa bean roasting, grinding, and then a controlled crystallization, where the processing conditions yields the desirable polymorph V to give chocolate its characteristic snap and texture. Raman spectroscopy is well known as a technique that can provide a non-contact, non-destructive analysis of chemical composition and molecular structure. Yet, excitation in the visible and near-infrared (532-785 nm) has not been possible for dark or milk chocolate because of the samples' overwhelming fluorescence. New technologies enabling Raman spectroscopy closer to shortwave infrared wavelengths, closer to 1000 nm, are likely to reduce fluorescence of chocolate and other highly fluorescent samples. Based on the successes of 1064 nm excitation to understand chocolate blooming, we hypothesized that 1000 nm excitation would also reduce fluorescence and enable Raman spectroscopy in dark and milk chocolates. We used dispersive Raman spectroscopy at 1000 nm to measure white, milk, and dark chocolate and cocoa nibs. The use of 1000 nm excitation effectively reduced fluorescence, enabling qualitative and quantitative Raman spectroscopy directly on chocolate samples. These feasibility studies indicate that 1000 nm Raman spectroscopy can be used to measure chocolate in a laboratory or process environment.
Collapse
Affiliation(s)
| | - Mary Lewis
- Endress+Hauser Optical Analysis, Ann Arbor, MI, USA
| | - Ian R Lewis
- Endress+Hauser Optical Analysis, Ann Arbor, MI, USA
| |
Collapse
|
5
|
Podunavac I, Djocos M, Vejin M, Birgermajer S, Pavlovic Z, Kojic S, Petrovic B, Radonic V. 3D-Printed Microfluidic Chip for Real-Time Glucose Monitoring in Liquid Analytes. MICROMACHINES 2023; 14:mi14030503. [PMID: 36984909 PMCID: PMC10052769 DOI: 10.3390/mi14030503] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/29/2023] [Revised: 02/11/2023] [Accepted: 02/15/2023] [Indexed: 05/31/2023]
Abstract
The connection of macrosystems with microsystems for in-line measurements is important in different biotechnological processes as it enables precise and accurate monitoring of process parameters at a small scale, which can provide valuable insights into the process, and ultimately lead to improved process control and optimization. Additionally, it allows continuous monitoring without the need for manual sampling and analysis, leading to more efficient and cost-effective production. In this paper, a 3D printed microfluidic (MF) chip for glucose (Glc) sensing in a liquid analyte is proposed. The chip made in Poly(methyl methacrylate) (PMMA) contains integrated serpentine-based micromixers realized via stereolithography with a slot for USB-like integration of commercial DropSens electrodes. After adjusting the sample's pH in the first micromixer, small volumes of the sample and enzyme are mixed in the second micromixer and lead to a sensing chamber where the Glc concentration is measured via chronoamperometry. The sensing potential was examined for Glc concentrations in acetate buffer in the range of 0.1-100 mg/mL and afterward tested for Glc sensing in a cell culturing medium. The proposed chip showed great potential for connection with macrosystems, such as bioreactors, for direct in-line monitoring of a quality parameter in a liquid sample.
Collapse
Affiliation(s)
- Ivana Podunavac
- University of Novi Sad, BioSense Institute, Dr Zorana Đinđića 1, 21000 Novi Sad, Serbia
| | - Miroslav Djocos
- University of Novi Sad, Faculty of Technical Sciences, Trg Dositeja Obradovića 6, 21000 Novi Sad, Serbia
| | - Marija Vejin
- University of Novi Sad, Faculty of Technical Sciences, Trg Dositeja Obradovića 6, 21000 Novi Sad, Serbia
| | - Slobodan Birgermajer
- University of Novi Sad, BioSense Institute, Dr Zorana Đinđića 1, 21000 Novi Sad, Serbia
| | - Zoran Pavlovic
- University of Novi Sad, BioSense Institute, Dr Zorana Đinđića 1, 21000 Novi Sad, Serbia
| | - Sanja Kojic
- University of Novi Sad, Faculty of Technical Sciences, Trg Dositeja Obradovića 6, 21000 Novi Sad, Serbia
| | - Bojan Petrovic
- University of Novi Sad, Faculty of Medicine, Hajduk Veljkova 3, 21000 Novi Sad, Serbia
| | - Vasa Radonic
- University of Novi Sad, BioSense Institute, Dr Zorana Đinđića 1, 21000 Novi Sad, Serbia
| |
Collapse
|
6
|
Nikita S, Mishra S, Gupta K, Runkana V, Gomes J, Rathore AS. Advances in bioreactor control for production of biotherapeutic products. Biotechnol Bioeng 2023; 120:1189-1214. [PMID: 36760086 DOI: 10.1002/bit.28346] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 02/08/2023] [Accepted: 02/08/2023] [Indexed: 02/11/2023]
Abstract
Advanced control strategies are well established in chemical, pharmaceutical, and food processing industries. Over the past decade, the application of these strategies is being explored for control of bioreactors for manufacturing of biotherapeutics. Most of the industrial bioreactor control strategies apply classical control techniques, with the control system designed for the facility at hand. However, with the recent progress in sensors, machinery, and industrial internet of things, and advancements in deeper understanding of the biological processes, coupled with the requirement of flexible production, the need to develop a robust and advanced process control system that can ease process intensification has emerged. This has further fuelled the development of advanced monitoring approaches, modeling techniques, process analytical technologies, and soft sensors. It is seen that proper application of these concepts can significantly improve bioreactor process performance, productivity, and reproducibility. This review is on the recent advancements in bioreactor control and its related aspects along with the associated challenges. This study also offers an insight into the future prospects for development of control strategies that can be designed for industrial-scale production of biotherapeutic products.
Collapse
Affiliation(s)
- Saxena Nikita
- Department of Chemical Engineering, DBT Centre of Excellence for Biopharmaceutical Technology, Indian Institute of Technology, Hauz Khas, Delhi, India
| | - Somesh Mishra
- Department of Chemical Engineering, DBT Centre of Excellence for Biopharmaceutical Technology, Indian Institute of Technology, Hauz Khas, Delhi, India
| | - Keshari Gupta
- TCS Research, Tata Consultancy Services Limited, Pune, India
| | | | - James Gomes
- Kusuma School of Biological Sciences, Indian Institute of Technology, Hauz Khas, Delhi, India
| | - Anurag S Rathore
- Department of Chemical Engineering, DBT Centre of Excellence for Biopharmaceutical Technology, Indian Institute of Technology, Hauz Khas, Delhi, India
| |
Collapse
|
7
|
Rathore AS, Thakur G, Kateja N. Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise? Biotechnol Bioeng 2023; 120:333-351. [PMID: 36111450 DOI: 10.1002/bit.28235] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2022] [Revised: 09/09/2022] [Accepted: 09/11/2022] [Indexed: 01/13/2023]
Abstract
Continuous integrated bioprocessing has elicited considerable interest from the biopharma industry for the many purported benefits it promises. Today many major biopharma manufacturers around the world are engaged in the development of continuous process platforms for their products. In spite of great potential, the path toward continuous integrated bioprocessing remains unclear for the biologics industry due to legacy infrastructure, process integration challenges, vague regulatory guidelines, and a diverging focus toward novel therapies. In this article, we present a review and perspective on this topic. We explore the status of the implementation of continuous integrated bioprocessing among biopharmaceutical manufacturers. We also present some of the key hurdles that manufacturers are likely to face during this implementation. Finally, we hypothesize that the real impact of continuous manufacturing is likely to come when the cost of manufacturing is a substantial portion of the cost of product development, such as in the case of biosimilar manufacturing and emerging economies.
Collapse
Affiliation(s)
- Anurag S Rathore
- Department of Chemical Engineering, Indian Institute of Technology, New Delhi, India
| | - Garima Thakur
- Department of Chemical Engineering, Indian Institute of Technology, New Delhi, India
| | - Nikhil Kateja
- Department of Chemical Engineering, Indian Institute of Technology, New Delhi, India
| |
Collapse
|
8
|
Graf A, Lemke J, Schulze M, Soeldner R, Rebner K, Hoehse M, Matuszczyk J. A Novel Approach for Non-Invasive Continuous In-Line Control of Perfusion Cell Cultivations by Raman Spectroscopy. Front Bioeng Biotechnol 2022; 10:719614. [PMID: 35547168 PMCID: PMC9081366 DOI: 10.3389/fbioe.2022.719614] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2021] [Accepted: 04/04/2022] [Indexed: 11/13/2022] Open
Abstract
Continuous manufacturing is becoming more important in the biopharmaceutical industry. This processing strategy is favorable, as it is more efficient, flexible, and has the potential to produce higher and more consistent product quality. At the same time, it faces some challenges, especially in cell culture. As a steady state has to be maintained over a prolonged time, it is unavoidable to implement advanced process analytical technologies to control the relevant process parameters in a fast and precise manner. One such analytical technology is Raman spectroscopy, which has proven its advantages for process monitoring and control mostly in (fed-) batch cultivations. In this study, an in-line flow cell for Raman spectroscopy is included in the cell-free harvest stream of a perfusion process. Quantitative models for glucose and lactate were generated based on five cultivations originating from varying bioreactor scales. After successfully validating the glucose model (Root Mean Square Error of Prediction (RMSEP) of ∼0.2 g/L), it was employed for control of an external glucose feed in cultivation with a glucose-free perfusion medium. The generated model was successfully applied to perform process control at 4 g/L and 1.5 g/L glucose over several days, respectively, with variability of ±0.4 g/L. The results demonstrate the high potential of Raman spectroscopy for advanced process monitoring and control of a perfusion process with a bioreactor and scale-independent measurement method.
Collapse
Affiliation(s)
- A. Graf
- Product Development, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| | - J. Lemke
- Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany
- *Correspondence: J. Lemke,
| | - M. Schulze
- Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| | - R. Soeldner
- Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| | - K. Rebner
- Process Analysis and Technology PA&T, Reutlingen University, Reutlingen, Germany
| | - M. Hoehse
- Product Development, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| | - J. Matuszczyk
- Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| |
Collapse
|
9
|
Gillespie C, Wasalathanthri DP, Ritz DB, Zhou G, Davis KA, Wucherpfennig T, Hazelwood N. Systematic assessment of process analytical technologies for biologics. Biotechnol Bioeng 2021; 119:423-434. [PMID: 34778948 DOI: 10.1002/bit.27990] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Revised: 10/18/2021] [Accepted: 11/01/2021] [Indexed: 12/22/2022]
Abstract
The application of process analytical technology (PAT) for biotherapeutic development and manufacturing has been employed owing to technological, economic, and regulatory advantages across the industry. Typically, chromatographic, spectroscopic, and/or mass spectrometric sensors are integrated into upstream and downstream unit operations in in-line, on-line, or at-line fashion to enable real-time monitoring and control of the process. Despite the widespread utility of PAT technologies at various unit operations of the bioprocess, a holistic business value assessment of PAT has not been well addressed in biologics. Thus, in this study, we evaluated PAT technologies based on predefined criteria for their technological attributes such as enablement of better process understanding, control, and high-throughput capabilities; as well as for business attributes such as simplicity of implementation, lead time, and cost reduction. The study involved an industry-wide survey, where input from subject matter industry experts on various PAT tools were collected, assessed, and ranked. The survey results demonstrated on-line liquid Chromatography (LC), in-line Raman, and gas analysis techniques are of high business value especially at the production bioreactor unit operation of upstream processing. In-line variable path-length UV/VIS measurements (VPE), on-line LC, multiangle light scattering (MALS), and automated sampling are of high business value in Protein A purification and polishing steps of the downstream process. We also provide insights, based on our experience in clinical and commercial manufacturing of biologics, into the development and implementation of some of the PAT tools. The results presented in this study are intended to be helpful for the current practitioners of PAT as well as those new to the field to gauge, prioritize and steer their projects for success.
Collapse
Affiliation(s)
| | | | - Diana B Ritz
- GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - George Zhou
- Merck & Co., Inc., Kenilworth, New Jersey, USA
| | | | | | | |
Collapse
|
10
|
A Gibbons L, Rafferty C, Robinson K, Abad M, Maslanka F, Le N, Mo J, Clark K, Madden F, Hayes R, McCarthy B, Rode C, O'Mahony J, Rea R, O'Mahony Hartnett C. Raman based chemometric model development for glycation and glycosylation real time monitoring in a manufacturing scale CHO cell bioreactor process. Biotechnol Prog 2021; 38:e3223. [PMID: 34738336 DOI: 10.1002/btpr.3223] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2021] [Revised: 10/07/2021] [Accepted: 11/02/2021] [Indexed: 11/09/2022]
Abstract
The Quality by Design (QbD) approach to the production of therapeutic monoclonal antibodies (mAbs) emphasizes an understanding of the production process ensuring product quality is maintained throughout. Current methods for measuring critical quality attributes (CQAs) such as glycation and glycosylation are time and resource intensive, often, only tested offline once per batch process. Process analytical technology (PAT) tools such as Raman spectroscopy combined with chemometric modeling can provide real time measurements process variables and are aligned with the QbD approach. This study utilizes these tools to build partial least squares (PLS) regression models to provide real time monitoring of glycation and glycosylation profiles. In total, seven cell line specific chemometric PLS models; % mono-glycated, % non-glycated, % G0F-GlcNac, % G0, % G0F, % G1F, and % G2F were considered. PLS models were initially developed using small scale data to verify the capability of Raman to measure these CQAs effectively. Accurate PLS model predictions were observed at small scale (5 L). At manufacturing scale (2000 L) some glycosylation models showed higher error, indicating that scale may be a key consideration in glycosylation profile PLS model development. Model robustness was then considered by supplementing models with a single batch of manufacturing scale data. This data addition had a significant impact on the predictive capability of each model, with an improvement of 77.5% in the case of the G2F. The finalized models show the capability of Raman as a PAT tool to deliver real time monitoring of glycation and glycosylation profiles at manufacturing scale.
Collapse
Affiliation(s)
- Luke A Gibbons
- BioTherapeutics Development, Janssen Sciences Ireland UC, Cork, Ireland.,Department of Biological Sciences, Munster Technological University, Cork, Ireland
| | - Carl Rafferty
- BioTherapeutics Development, Janssen Sciences Ireland UC, Cork, Ireland
| | - Kerry Robinson
- Analytical Development, Janssen Pharmaceutical Companies of Johnson and Johnson, Malvern, Pennsylvania, USA
| | - Marta Abad
- BioTherapeutics Development, Janssen Pharmaceutical Companies of Johnson and Johnson, Malvern, Pennsylvania, USA
| | - Francis Maslanka
- BioTherapeutics Development, Janssen Pharmaceutical Companies of Johnson and Johnson, Malvern, Pennsylvania, USA
| | - Nikky Le
- BioTherapeutics Development, Janssen Pharmaceutical Companies of Johnson and Johnson, Malvern, Pennsylvania, USA
| | - Jingjie Mo
- Analytical Development, Janssen Pharmaceutical Companies of Johnson and Johnson, Malvern, Pennsylvania, USA
| | - Kevin Clark
- BioTherapeutics Development, Janssen Pharmaceutical Companies of Johnson and Johnson, Malvern, Pennsylvania, USA
| | - Fiona Madden
- BioTherapeutics Development, Janssen Sciences Ireland UC, Cork, Ireland
| | - Ronan Hayes
- BioTherapeutics Development, Janssen Sciences Ireland UC, Cork, Ireland
| | - Barry McCarthy
- BioTherapeutics Development, Janssen Sciences Ireland UC, Cork, Ireland
| | - Christopher Rode
- BioTherapeutics Development, Janssen Pharmaceutical Companies of Johnson and Johnson, Malvern, Pennsylvania, USA
| | - Jim O'Mahony
- Department of Biological Sciences, Munster Technological University, Cork, Ireland
| | - Rosemary Rea
- Department of Biological Sciences, Munster Technological University, Cork, Ireland
| | | |
Collapse
|
11
|
The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing. Anal Bioanal Chem 2021; 414:969-991. [PMID: 34668998 PMCID: PMC8724084 DOI: 10.1007/s00216-021-03727-4] [Citation(s) in RCA: 26] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Accepted: 10/08/2021] [Indexed: 12/21/2022]
Abstract
Biopharmaceuticals have revolutionized the field of medicine in the types of active ingredient molecules and treatable indications. Adoption of Quality by Design and Process Analytical Technology (PAT) frameworks has helped the biopharmaceutical field to realize consistent product quality, process intensification, and real-time control. As part of the PAT strategy, Raman spectroscopy offers many benefits and is used successfully in bioprocessing from single-cell analysis to cGMP process control. Since first introduced in 2011 for industrial bioprocessing applications, Raman has become a first-choice PAT for monitoring and controlling upstream bioprocesses because it facilitates advanced process control and enables consistent process quality. This paper will discuss new frontiers in extending these successes in upstream from scale-down to commercial manufacturing. New reports concerning the use of Raman spectroscopy in the basic science of single cells and downstream process monitoring illustrate industrial recognition of Raman’s value throughout a biopharmaceutical product’s lifecycle. Finally, we draw upon a nearly 90-year history in biological Raman spectroscopy to provide the basis for laboratory and in-line measurements of protein quality, including higher-order structure and composition modifications, to support formulation development.
Collapse
|
12
|
Schie IW, Stiebing C, Popp J. Looking for a perfect match: multimodal combinations of Raman spectroscopy for biomedical applications. JOURNAL OF BIOMEDICAL OPTICS 2021; 26:JBO-210137VR. [PMID: 34387049 PMCID: PMC8358667 DOI: 10.1117/1.jbo.26.8.080601] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Accepted: 07/16/2021] [Indexed: 06/13/2023]
Abstract
Raman spectroscopy has shown very promising results in medical diagnostics by providing label-free and highly specific molecular information of pathological tissue ex vivo and in vivo. Nevertheless, the high specificity of Raman spectroscopy comes at a price, i.e., low acquisition rate, no direct access to depth information, and limited sampling areas. However, a similar case regarding advantages and disadvantages can also be made for other highly regarded optical modalities, such as optical coherence tomography, autofluorescence imaging and fluorescence spectroscopy, fluorescence lifetime microscopy, second-harmonic generation, and others. While in these modalities the acquisition speed is significantly higher, they have no or only limited molecular specificity and are only sensitive to a small group of molecules. It can be safely stated that a single modality provides only a limited view on a specific aspect of a biological specimen and cannot assess the entire complexity of a sample. To solve this issue, multimodal optical systems, which combine different optical modalities tailored to a particular need, become more and more common in translational research and will be indispensable diagnostic tools in clinical pathology in the near future. These systems can assess different and partially complementary aspects of a sample and provide a distinct set of independent biomarkers. Here, we want to give an overview on the development of multimodal systems that use RS in combination with other optical modalities to improve the diagnostic performance.
Collapse
Affiliation(s)
- Iwan W. Schie
- Leibniz Institute of Photonic Technology, Jena, Germany
- University of Applied Sciences—Jena, Department for Medical Engineering and Biotechnology, Jena, Germany
| | | | - Jürgen Popp
- Leibniz Institute of Photonic Technology, Jena, Germany
- Friedrich Schiller University Jena, Institute of Physical Chemistry and Abbe Center of Photonics, Jena, Germany
| |
Collapse
|
13
|
Rolinger L, Rüdt M, Hubbuch J. Comparison of UV- and Raman-based monitoring of the Protein A load phase and evaluation of data fusion by PLS models and CNNs. Biotechnol Bioeng 2021; 118:4255-4268. [PMID: 34297358 DOI: 10.1002/bit.27894] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Revised: 06/16/2021] [Accepted: 07/09/2021] [Indexed: 12/30/2022]
Abstract
A promising application of Process Analytical Technology to the downstream process of monoclonal antibodies (mAbs) is the monitoring of the Protein A load phase as its control promises economic benefits. Different spectroscopic techniques have been evaluated in literature with regard to the ability to quantify the mAb concentration in the column effluent. Raman and Ultraviolet (UV) spectroscopy are among the most promising techniques. In this study, both were investigated in an in-line setup and directly compared. The data of each sensor were analyzed independently with Partial-Least-Squares (PLS) models and Convolutional Neural Networks (CNNs) for regression. Furthermore, data fusion strategies were investigated by combining both sensors in hierarchical PLS models or in CNNs. Among the tested options, UV spectroscopy alone allowed for the most precise and accurate prediction of the mAb concentration. A Root Mean Square Error of Prediction (RMSEP) of 0.013 g L-1 was reached with the UV-based PLS model. The Raman-based PLS model reached an RMSEP of 0.232 g L-1 . The different data fusion techniques did not improve the prediction accuracy above the prediction accuracy of the UV-based PLS model. Data fusion by PLS models seems meritless when combining a very accurate sensor with a less accurate signal. Furthermore, the application of CNNs for UV and Raman spectra did not yield significant improvements in the prediction quality. For the presented application, linear regression techniques seem to be better suited compared with advanced nonlinear regression techniques, like, CNNs. In summary, the results support the application of UV spectroscopy and PLS modeling for future research and development activities aiming to implement spectroscopic real-time monitoring of the Protein A load phase.
Collapse
Affiliation(s)
- Laura Rolinger
- Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology, Karlsruhe, Germany.,PTDC-P PAT, Hoffmann-La Roche AG, Basel, Switzerland
| | - Matthias Rüdt
- Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology, Karlsruhe, Germany.,Haute Ecole d'Ingénierie, HES-SO Valais-Wallis, Sion, Switzerland
| | - Jürgen Hubbuch
- Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology, Karlsruhe, Germany
| |
Collapse
|
14
|
Djisalov M, Knežić T, Podunavac I, Živojević K, Radonic V, Knežević NŽ, Bobrinetskiy I, Gadjanski I. Cultivating Multidisciplinarity: Manufacturing and Sensing Challenges in Cultured Meat Production. BIOLOGY 2021; 10:204. [PMID: 33803111 PMCID: PMC7998526 DOI: 10.3390/biology10030204] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 02/28/2021] [Accepted: 03/02/2021] [Indexed: 12/11/2022]
Abstract
Meat cultivation via cellular agriculture holds great promise as a method for future food production. In theory, it is an ideal way of meat production, humane to the animals and sustainable for the environment, while keeping the same taste and nutritional values as traditional meat and having additional benefits such as controlled fat content and absence of antibiotics and hormones used in the traditional meat industry. However, in practice, there is still a number of challenges, such as those associated with the upscale of cultured meat (CM). CM food safety monitoring is a necessary factor when envisioning both the regulatory compliance and consumer acceptance. To achieve this, a multidisciplinary approach is necessary. This includes extensive development of the sensitive and specific analytical devices i.e., sensors to enable reliable food safety monitoring throughout the whole future food supply chain. In addition, advanced monitoring options can help in the further optimization of the meat cultivation which may reduce the currently still high costs of production. This review presents an overview of the sensor monitoring options for the most relevant parameters of importance for meat cultivation. Examples of the various types of sensors that can potentially be used in CM production are provided and the options for their integration into bioreactors, as well as suggestions on further improvements and more advanced integration approaches. In favor of the multidisciplinary approach, we also include an overview of the bioreactor types, scaffolding options as well as imaging techniques relevant for CM research. Furthermore, we briefly present the current status of the CM research and related regulation, societal aspects and challenges to its upscaling and commercialization.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Ivana Gadjanski
- BioSense Institute, University of Novi Sad, Dr Zorana Djindjica 1, 21000 Novi Sad, Serbia; (M.Dj.); (T.K.); (I.P.); (K.Ž.); (V.R.); (N.Ž.K.); (I.B.)
| |
Collapse
|
15
|
Rathore AS, Nikita S, Thakur G, Deore N. Challenges in process control for continuous processing for production of monoclonal antibody products. Curr Opin Chem Eng 2021. [DOI: 10.1016/j.coche.2021.100671] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
16
|
W Eyster T, Talwar S, Fernandez J, Foster S, Hayes J, Allen R, Reidinger S, Wan B, Ji X, Aon J, Patel P, Ritz DB. Tuning monoclonal antibody galactosylation using Raman spectroscopy-controlled lactic acid feeding. Biotechnol Prog 2020; 37:e3085. [PMID: 32975043 DOI: 10.1002/btpr.3085] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2020] [Revised: 09/10/2020] [Accepted: 09/15/2020] [Indexed: 01/30/2023]
Abstract
A key aspect of large-scale production of biotherapeutics is a well-designed and consistently-executed upstream cell culture process. Process analytical technology tools provide enhanced monitoring and control capabilities to support consistent process execution, and also have potential to aid in maintenance of product quality at desired levels. One such tool, Raman spectroscopy, has matured as a useful technique to achieve real-time monitoring and control of key cell culture process attributes. We developed a Raman spectroscopy-based nutrient control strategy to enable dual control of lactate and glucose levels for a fed-batch CHO cell culture process for monoclonal antibody (mAb) production. To achieve this, partial least squares-based chemometric models for real-time prediction of glucose and lactate concentrations were developed and deployed in feedback control loops. In particular, feeding of lactic acid post-metabolic shift was investigated based on previous work that has shown the impact of lactate levels on ammonium as well as mAb product quality. Three feeding strategies were assessed for impact on cell metabolism, productivity, and product quality: bolus-fed glucose, glucose control at 4 g/L, or simultaneous glucose control at 4 g/L and lactate control at 2 g/L. The third feeding strategy resulted in a significant reduction in ammonium levels (68%) while increasing mAb galactosylation levels by approximately 50%. This work demonstrated that when deployed in a cell culture process, Raman spectroscopy is an effective technique for simultaneous control of multiple nutrient feeds, and that lactic acid feeding can have a positive impact on both cell metabolism and mAb product quality.
Collapse
Affiliation(s)
- Thomas W Eyster
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Sameer Talwar
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Janice Fernandez
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Shelby Foster
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - James Hayes
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Randal Allen
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Scot Reidinger
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Boyong Wan
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Xiaodan Ji
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Juan Aon
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Pramthesh Patel
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| | - Diana B Ritz
- Microbial & Cell Culture Development, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
| |
Collapse
|
17
|
High-Throughput Raman Spectroscopy Combined with Innovate Data Analysis Workflow to Enhance Biopharmaceutical Process Development. Processes (Basel) 2020. [DOI: 10.3390/pr8091179] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Raman spectroscopy has the potential to revolutionise many aspects of biopharmaceutical process development. The widespread adoption of this promising technology has been hindered by the high cost associated with individual probes and the challenge of measuring low sample volumes. To address these issues, this paper investigates the potential of an emerging new high-throughput (HT) Raman spectroscopy microscope combined with a novel data analysis workflow to replace off-line analytics for upstream and downstream operations. On the upstream front, the case study involved the at-line monitoring of an HT micro-bioreactor system cultivating two mammalian cell cultures expressing two different therapeutic proteins. The spectra generated were analysed using a partial least squares (PLS) model. This enabled the successful prediction of the glucose, lactate, antibody, and viable cell density concentrations directly from the Raman spectra without reliance on multiple off-line analytical devices and using only a single low-volume sample (50–300 μL). However, upon the subsequent investigation of these models, only the glucose and lactate models appeared to be robust based upon their model coefficients containing the expected Raman vibrational signatures. On the downstream front, the HT Raman device was incorporated into the development of a cation exchange chromatography step for an Fc-fusion protein to compare different elution conditions. PLS models were derived from the spectra and were found to predict accurately monomer purity and concentration. The low molecular weight (LMW) and high molecular weight (HMW) species concentrations were found to be too low to be predicted accurately by the Raman device. However, the method enabled the classification of samples based on protein concentration and monomer purity, allowing a prioritisation and reduction in samples analysed using A280 UV absorbance and high-performance liquid chromatography (HPLC). The flexibility and highly configurable nature of this HT Raman spectroscopy microscope makes it an ideal tool for bioprocess research and development, and is a cost-effective solution based on its ability to support a large range of unit operations in both upstream and downstream process operations.
Collapse
|
18
|
Tang Y, Petropoulos K, Kurth F, Gao H, Migliorelli D, Guenat O, Generelli S. Screen-Printed Glucose Sensors Modified with Cellulose Nanocrystals (CNCs) for Cell Culture Monitoring. BIOSENSORS-BASEL 2020; 10:bios10090125. [PMID: 32933204 PMCID: PMC7557574 DOI: 10.3390/bios10090125] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Revised: 09/10/2020] [Accepted: 09/11/2020] [Indexed: 01/03/2023]
Abstract
Glucose sensors are potentially useful tools for monitoring the glucose concentration in cell culture medium. Here, we present a new, low-cost, and reproducible sensor based on a cellulose-based material, 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) oxidized-cellulose nanocrystals (CNCs). This novel biocompatible and inert nanomaterial is employed as a polymeric matrix to immobilize and stabilize glucose oxidase in the fabrication of a reproducible, operationally stable, highly selective, cost-effective, screen-printed glucose sensor. The sensors have a linear range of 0.1–2 mM (R2 = 0.999) and a sensitivity of 5.7 ± 0.3 µA cm−2∙mM−1. The limit of detection is 0.004 mM, and the limit of quantification is 0.015 mM. The sensor maintains 92.3 % of the initial current response after 30 consecutive measurements in a 1 mM standard glucose solution, and has a shelf life of 1 month while maintaining high selectivity. We demonstrate the practical application of the sensor by monitoring the glucose consumption of a fibroblast cell culture over the course of several days.
Collapse
Affiliation(s)
- Ye Tang
- Swiss Center for Electronics and Microtechnology (CSEM, Landquart), Bahnhofstrasse 1, 7302 Landquart, Switzerland; (Y.T.); (K.P.); (F.K.); (H.G.); (D.M.)
- Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research, University of Bern, Murtenstrasse 50, 3008 Bern, Switzerland;
| | - Konstantinos Petropoulos
- Swiss Center for Electronics and Microtechnology (CSEM, Landquart), Bahnhofstrasse 1, 7302 Landquart, Switzerland; (Y.T.); (K.P.); (F.K.); (H.G.); (D.M.)
| | - Felix Kurth
- Swiss Center for Electronics and Microtechnology (CSEM, Landquart), Bahnhofstrasse 1, 7302 Landquart, Switzerland; (Y.T.); (K.P.); (F.K.); (H.G.); (D.M.)
| | - Hui Gao
- Swiss Center for Electronics and Microtechnology (CSEM, Landquart), Bahnhofstrasse 1, 7302 Landquart, Switzerland; (Y.T.); (K.P.); (F.K.); (H.G.); (D.M.)
| | - Davide Migliorelli
- Swiss Center for Electronics and Microtechnology (CSEM, Landquart), Bahnhofstrasse 1, 7302 Landquart, Switzerland; (Y.T.); (K.P.); (F.K.); (H.G.); (D.M.)
| | - Olivier Guenat
- Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research, University of Bern, Murtenstrasse 50, 3008 Bern, Switzerland;
| | - Silvia Generelli
- Swiss Center for Electronics and Microtechnology (CSEM, Landquart), Bahnhofstrasse 1, 7302 Landquart, Switzerland; (Y.T.); (K.P.); (F.K.); (H.G.); (D.M.)
- Correspondence: ; Tel.: +41-81-307-8139
| |
Collapse
|
19
|
Yilmaz D, Mehdizadeh H, Navarro D, Shehzad A, O'Connor M, McCormick P. Application of Raman spectroscopy in monoclonal antibody producing continuous systems for downstream process intensification. Biotechnol Prog 2020; 36:e2947. [DOI: 10.1002/btpr.2947] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2019] [Revised: 11/24/2019] [Accepted: 12/09/2019] [Indexed: 12/21/2022]
Affiliation(s)
- Denizhan Yilmaz
- Global Technology & Engineering, Pfizer Global Supply, Pfizer Inc., Peapack New Jersey
| | - Hamidreza Mehdizadeh
- Global Technology & Engineering, Pfizer Global Supply, Pfizer Inc., Peapack New Jersey
| | - Dunie Navarro
- Bioprocess Research & Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc. Chesterfield Missouri
| | - Amar Shehzad
- Bioprocess Research & Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc. Andover Massachusetts
| | - Michael O'Connor
- Bioprocess Research & Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc. Andover Massachusetts
| | - Philip McCormick
- Bioprocess Research & Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc. Chesterfield Missouri
| |
Collapse
|
20
|
Rafferty C, O'Mahony J, Burgoyne B, Rea R, Balss KM, Latshaw DC. Raman spectroscopy as a method to replace off‐line pH during mammalian cell culture processes. Biotechnol Bioeng 2019; 117:146-156. [DOI: 10.1002/bit.27197] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2019] [Revised: 09/11/2019] [Accepted: 10/15/2019] [Indexed: 01/10/2023]
Affiliation(s)
- Carl Rafferty
- Janssen Sciences Ireland UC, BioTherapeutic Development Cork Ireland
- Cork Institute of Technology, Biological Sciences Cork Ireland
| | - Jim O'Mahony
- Cork Institute of Technology, Biological Sciences Cork Ireland
| | - Barbara Burgoyne
- Janssen Sciences Ireland UC, Product Quality Management Cork Ireland
| | - Rosemary Rea
- Cork Institute of Technology, Biological Sciences Cork Ireland
| | - Karin M. Balss
- Janssen Pharmaceutical Companies of Johnson and Johnson, Process Science and Advanced Analytics New Jersey
| | - David C. Latshaw
- Janssen Pharmaceutical Companies of Johnson and Johnson, Process Science and Advanced Analytics New Jersey
| |
Collapse
|
21
|
Möller J, Bhat K, Riecken K, Pörtner R, Zeng AP, Jandt U. Process-induced cell cycle oscillations in CHO cultures: Online monitoring and model-based investigation. Biotechnol Bioeng 2019; 116:2931-2943. [PMID: 31342512 DOI: 10.1002/bit.27124] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2019] [Revised: 07/05/2019] [Accepted: 07/19/2019] [Indexed: 01/04/2023]
Abstract
The influence of process strategies on the dynamics of cell population heterogeneities in mammalian cell culture is still not well understood. We recently found that the progression of cells through the cell cycle causes metabolic regulations with variable productivities in antibody-producing Chimese hamster ovary (CHO) cells. On the other hand, it is so far unknown how bulk cultivation conditions, for example, variable nutrient concentrations depending on process strategies, can influence cell cycle-derived population dynamics. In this study, process-induced cell cycle synchronization was assessed in repeated-batch and fed-batch cultures. An automated flow cytometry set-up was developed to measure the cell cycle distribution online, using antibody-producing CHO DP-12 cells transduced with the cell cycle-specific fluorescent ubiquitination-based cell cycle indicator (FUCCI) system. On the basis of the population-resolved model, feeding-induced partial self-synchronization was predicted and the results were evaluated experimentally. In the repeated-batch culture, stable cell cycle oscillations were confirmed with an oscillating G1 phase distribution between 41% and 72%. Furthermore, oscillations of the cell cycle distribution were simulated and determined in a (bolus) fed-batch process with up to 25 × 1 0 6 cells/ml. The cell cycle synchronization arose with pulse feeding only and ceased with continuous feeding. Both simulated and observed oscillations occurred at higher frequencies than those observable based on regular (e.g., daily) sample analysis, thus demonstrating the need for high-frequency online cell cycle analysis. In summary, we showed how experimental methods combined with simulations enable the improved assessment of the effects of process strategies on the dynamics of cell cycle-dependent population heterogeneities. This provides a novel approach to understand cell cycle regulations, control cell population dynamics, avoid inadvertently induced oscillations of cell cycle distributions and thus to improve process stability and efficiency.
Collapse
Affiliation(s)
- Johannes Möller
- Bioprocess and Biosystems Engineering, Hamburg University of Technology, Hamburg, Germany
| | - Krathika Bhat
- Bioprocess and Biosystems Engineering, Hamburg University of Technology, Hamburg, Germany
| | - Kristoffer Riecken
- Department of Stem Cell Transplantation, Research Department Cell and Gene Therapy, University Medical Centre (UMC) Hamburg-Eppendorf, Hamburg, Germany
| | - Ralf Pörtner
- Bioprocess and Biosystems Engineering, Hamburg University of Technology, Hamburg, Germany
| | - An-Ping Zeng
- Bioprocess and Biosystems Engineering, Hamburg University of Technology, Hamburg, Germany
| | - Uwe Jandt
- Bioprocess and Biosystems Engineering, Hamburg University of Technology, Hamburg, Germany
| |
Collapse
|